Edwards Lifesciences Corp (EW)
85.06
+0.76
(+0.90%)
USD |
NYSE |
May 02, 16:00
85.03
-0.03
(-0.04%)
Pre-Market: 20:00
Edwards Lifesciences Cash and Short Term Investments (Quarterly): 1.698B for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.698B |
December 31, 2023 | 1.644B |
September 30, 2023 | 1.864B |
June 30, 2023 | 1.509B |
March 31, 2023 | 1.254B |
December 31, 2022 | 1.215B |
September 30, 2022 | 1.739B |
June 30, 2022 | 1.516B |
March 31, 2022 | 1.496B |
December 31, 2021 | 1.467B |
September 30, 2021 | 1.795B |
June 30, 2021 | 1.561B |
March 31, 2021 | 1.331B |
December 31, 2020 | 1.403B |
September 30, 2020 | 1.295B |
June 30, 2020 | 1.164B |
March 31, 2020 | 1.031B |
December 31, 2019 | 1.517B |
September 30, 2019 | 1.357B |
June 30, 2019 | 934.30M |
March 31, 2019 | 963.00M |
December 31, 2018 | 956.50M |
September 30, 2018 | 1.596B |
June 30, 2018 | 1.401B |
March 31, 2018 | 1.499B |
Date | Value |
---|---|
December 31, 2017 | 1.338B |
September 30, 2017 | 1.403B |
June 30, 2017 | 1.132B |
March 31, 2017 | 918.20M |
December 31, 2016 | 1.271B |
September 30, 2016 | 1.200B |
June 30, 2016 | 1.060B |
March 31, 2016 | 951.80M |
December 31, 2015 | 1.225B |
September 30, 2015 | 1.250B |
June 30, 2015 | 1.409B |
March 31, 2015 | 1.371B |
December 31, 2014 | 1.439B |
September 30, 2014 | 1.515B |
June 30, 2014 | 1.484B |
March 31, 2014 | 831.60M |
December 31, 2013 | 936.90M |
September 30, 2013 | 757.60M |
June 30, 2013 | 575.00M |
March 31, 2013 | 557.90M |
December 31, 2012 | 521.40M |
September 30, 2012 | 622.50M |
June 30, 2012 | 506.00M |
March 31, 2012 | 409.50M |
December 31, 2011 | 450.50M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
934.30M
Minimum
Jun 2019
1.864B
Maximum
Sep 2023
1.439B
Average
1.481B
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Stryker Corp | 2.407B |
Boston Scientific Corp | 2.329B |
Abbott Laboratories | 7.279B |
Align Technology Inc | 898.91M |
Steris PLC | 195.58M |